Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-26-331541
Filing Date
2026-08-04
Accepted
2026-08-04 07:13:59
Documents
84
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q beam-20260630.htm   iXBRL 10-Q 2778047
2 EX-10.1 beam-ex10_1.htm EX-10.1 107647
3 EX-31.1 beam-ex31_1.htm EX-31.1 19656
4 EX-31.2 beam-ex31_2.htm EX-31.2 29918
5 EX-32.1 beam-ex32_1.htm EX-32.1 11794
6 EX-32.2 beam-ex32_2.htm EX-32.2 10912
  Complete submission text file 0001193125-26-331541.txt   12347478

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT beam-20260630.xsd EX-101.SCH 1647955
88 EXTRACTED XBRL INSTANCE DOCUMENT beam-20260630_htm.xml XML 2447271
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 261235433
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)